- Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
- Allurion to Participate in Two Upcoming Investor Conferences in June 2024
- Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
- Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
- Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
- Allurion Announces Preliminary First Quarter 2024 Results
- Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
- Allurion Expands Virtual Care Suite to the United States
- Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
- Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
More ▼
Key statistics
On Friday, Allurion Technologies Inc (ALUR:NYQ) closed at 1.51, 1.34% above its 52-week low of 1.49, set on May 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.56 |
---|---|
High | 1.62 |
Low | 1.51 |
Bid | 1.00 |
Offer | 1.90 |
Previous close | 1.51 |
Average volume | 72.72k |
---|---|
Shares outstanding | 47.95m |
Free float | 36.41m |
P/E (TTM) | -- |
Market cap | 72.40m USD |
EPS (TTM) | -1.37 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:10 BST.
More ▼